Pharmacological management of Ewing sarcoma family of tumours.

about

Current treatment for Ewing's sarcoma Ewing sarcoma family of tumors: a model for the new era of integrated laboratory diagnostics.TRAIL receptor signaling and therapeutic option in bone tumors: the trap of the bone microenvironment.

P2860

Q28248896-22554A98-64A0-4F33-9449-A4C3FF0FC82B Q37035288-8F65EAD6-0334-4C6E-BCF6-9B1862E3D78F Q37972139-4EE562E7-BA83-4517-A4C7-64D50AB90142

P2860

Pharmacological management of Ewing sarcoma family of tumours.

Item

http://www.wikidata.org/entity/Q35784021

description

2004 nî lūn-bûn

@nan

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

2004年论文

@zh

2004年论文

@zh-cn

name

Pharmacological management of Ewing sarcoma family of tumours.

@ast

Pharmacological management of Ewing sarcoma family of tumours.

@en

type

Item

label

Pharmacological management of Ewing sarcoma family of tumours.

@ast

Pharmacological management of Ewing sarcoma family of tumours.

@en

prefLabel

Pharmacological management of Ewing sarcoma family of tumours.

@ast

Pharmacological management of Ewing sarcoma family of tumours.

@en

P1476

Pharmacological management of Ewing sarcoma family of tumours.

@en

P2093

Carlos Rodriguez-Galindo

http://www.w3.org/2001/XMLSchema#string

P2860

Lessons learned from the development of an abl tyrosine kinase inhibitor for chronic myelogenous leukemia

Hematologic abnormalities and acute myeloid leukemia in children and adolescents administered intensified chemotherapy for the Ewing sarcoma family of tumors.

Successful treatment of metastatic renal cell carcinoma with a nonmyeloablative allogeneic peripheral-blood progenitor-cell transplant: evidence for a graft-versus-tumor effect.

Clinical use of topoisomerase I inhibitors in anticancer treatment.

Histone deacetylase inhibitors as new cancer drugs.

Downregulation and forced expression of EWS-Fli1 fusion gene results in changes in the expression of G(1)regulatory genes.

Therapeutic potentialities of EWS-Fli-1 mRNA-targeted vectorized antisense oligonucleotides.

The epidermal growth factor receptor HER2 is not a major therapeutic target in Ewing sarcoma.

The prognostic and therapeutic relevance of p27kip1 in Ewing's family tumors.

Effects of 4-hydroperoxy ifosfamide in combination with other anticancer agents on human cancer cell lines.

P304

1257-1270

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1517/14656566.5.6.1257

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2004-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15163271

http://www.w3.org/2001/XMLSchema#string

Pharmacological management of Ewing sarcoma family of tumours.

about

P2860

P2860

Pharmacological management of Ewing sarcoma family of tumours.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P577

P698